Nanjing Zenshine Pharmaceuticals Co., Ltd.
PrivateLast Round
Series C
Oct 13, 2023
Est. Valuation
$243M
Total Funding Raised
$78M
Company Overview
Nanjing Zenshine Pharmaceuticals Co., Ltd. is a biopharmaceutical company that discovers, develops, and commercializes innovative therapeutics for viral infectious diseases, oncology, and inflammatory disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nanjing Zenshine Pharmaceuticals Co., Ltd. Comparables
Compare Nanjing Zenshine Pharmaceuticals Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ginkgo Pharmaceutical (Suzhou) Co., Ltd. | 85% | |
| Sunflower Pharmaceuticals Group Co Ltd | 83% | |
| Qingfeng Pharmaceutical Group | 83% |
For institutional investors. Book with your work email.
Nanjing Zenshine Pharmaceuticals Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Oct 13, 2023 | ||||
| Series B | Mar 13, 2023 | ||||
| Series A Extension | Jun 6, 2021 | ||||
| Series A | Dec 31, 2020 | ||||
| Early Funding | Jun 22, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Nanjing Zenshine Pharmaceuticals Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Matrix | Series A Extension |
| LYZZ Capital | Series A Extension |
| MPC | Series B |
| Ennovation Ventures | Series B, Early Funding |
| State Development and Investment Group Co., Ltd. | Series A Extension |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors increased 857% MoM.
- Oct 27, 2024
Monthly visitors grew 98% MoM.
For institutional investors. Book with your work email.
Nanjing Zenshine Pharmaceuticals Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Nanjing Zenshine Pharmaceuticals Co., Ltd.'s valuation, stock price, and market status.
Is Nanjing Zenshine Pharmaceuticals Co., Ltd. a public or private company?
Nanjing Zenshine Pharmaceuticals Co., Ltd. is a private company.
What is the current stock price of Nanjing Zenshine Pharmaceuticals Co., Ltd.?
Nanjing Zenshine Pharmaceuticals Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Nanjing Zenshine Pharmaceuticals Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Nanjing Zenshine Pharmaceuticals Co., Ltd. worth (valuation)?
Nanjing Zenshine Pharmaceuticals Co., Ltd.'s valuation is estimated at $243.0M based on funding round data.
Can I buy Nanjing Zenshine Pharmaceuticals Co., Ltd. stock?
Nanjing Zenshine Pharmaceuticals Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Nanjing Zenshine Pharmaceuticals Co., Ltd.'s last funding round?
Nanjing Zenshine Pharmaceuticals Co., Ltd.'s most recent funding round was Series C on October 13, 2023.
Who are the main investors in Nanjing Zenshine Pharmaceuticals Co., Ltd.?
Key investors in Nanjing Zenshine Pharmaceuticals Co., Ltd. include State Development and Investment Group Co., Ltd..
Will Nanjing Zenshine Pharmaceuticals Co., Ltd. IPO soon?
No public IPO plans have been announced for Nanjing Zenshine Pharmaceuticals Co., Ltd..
How can I track Nanjing Zenshine Pharmaceuticals Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Nanjing Zenshine Pharmaceuticals Co., Ltd.'s shares on secondary markets.